GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (LSE:BXP) » Definitions » Cyclically Adjusted Book per Share

Beximco Pharmaceuticals (LSE:BXP) Cyclically Adjusted Book per Share : £0.41 (As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Beximco Pharmaceuticals Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Beximco Pharmaceuticals's adjusted book value per share for the three months ended in Dec. 2024 was £0.697. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is £0.41 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Beximco Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was 9.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -0.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Beximco Pharmaceuticals was -0.50% per year. The lowest was -7.50% per year. And the median was -5.90% per year.

As of today (2025-05-22), Beximco Pharmaceuticals's current stock price is £0.36. Beximco Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was £0.41. Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.88.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Beximco Pharmaceuticals was 3.03. The lowest was 0.58. And the median was 1.31.


Beximco Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

The historical data trend for Beximco Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Cyclically Adjusted Book per Share Chart

Beximco Pharmaceuticals Annual Data
Trend Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.41 0.35 0.19 0.27

Beximco Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.27 0.27 0.28 0.41

Competitive Comparison of Beximco Pharmaceuticals's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


;
;

Beximco Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Beximco Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.697/133.1571*133.1571
=0.697

Current CPI (Dec. 2024) = 133.1571.

Beximco Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201409 0.288 100.428 0.382
201412 0.293 99.070 0.394
201503 0.299 99.621 0.400
201506 0.302 100.684 0.399
201509 0.308 100.392 0.409
201512 0.000 99.792 0.000
201609 0.330 101.861 0.431
201612 0.336 101.863 0.439
201703 0.343 102.862 0.444
201706 0.352 103.349 0.454
201709 0.360 104.136 0.460
201712 0.363 104.011 0.465
201803 0.371 105.290 0.469
201806 0.380 106.317 0.476
201809 0.390 106.507 0.488
201812 0.393 105.998 0.494
201903 0.404 107.251 0.502
201906 0.415 108.070 0.511
201909 0.427 108.329 0.525
201912 0.430 108.420 0.528
202003 0.443 108.902 0.542
202006 0.456 108.767 0.558
202009 0.471 109.815 0.571
202012 0.478 109.897 0.579
202103 0.499 111.754 0.595
202106 0.519 114.631 0.603
202109 0.540 115.734 0.621
202112 0.542 117.630 0.614
202203 0.557 121.301 0.611
202206 0.569 125.017 0.606
202209 0.590 125.227 0.627
202212 0.585 125.222 0.622
202303 0.598 127.348 0.625
202306 0.612 128.729 0.633
202309 0.000 129.860 0.000
202312 0.632 129.419 0.650
202403 0.652 131.776 0.659
202406 0.672 132.554 0.675
202409 0.696 133.029 0.697
202412 0.697 133.157 0.697

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Beximco Pharmaceuticals  (LSE:BXP) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Beximco Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.36/0.41
=0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Beximco Pharmaceuticals was 3.03. The lowest was 0.58. And the median was 1.31.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Beximco Pharmaceuticals Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Beximco Pharmaceuticals Business Description

Traded in Other Exchanges
Address
19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.

Beximco Pharmaceuticals Headlines